Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data
Keyword(s):
2019 ◽
Vol 22
(4)
◽
pp. 306-318
◽
2018 ◽
Vol 93
(9)
◽
pp. E224-E225
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽